Page 101 - 《中国药房》2023年19期

TPO-RA类药物的ADE信号进行了挖掘与分析，发现罗 [10] CASTELLI R，GIDARO A，DELILIERS G L. Risk of
米司亭与艾曲泊帕的ADE主要累及血液及淋巴系统；发 thrombosis in elderly immune primary trombocytopenic
生频次位居前列的ADE信号均与血小板有关，与其药品 patients treated with thrombopoietin receptors agonists[J].
说明书基本一致；根据各自的ADE信号强度判断，罗米 J Thromb Thrombolysis，2020，50（4）：903-907.
司亭的 TPO 水平异常和艾曲泊帕的登革病毒检测阳性 [11] KAWANO N，HASUIKE S，IWAKIRI H，et al. Portal
排在首位，且均为其药品说明书未提及的ADE。虽然信 vein thrombosis during eltrombopag treatment for im‐
号挖掘结果只能提示ADE风险增加的潜在可能，其因果 mune thrombocytopenic purpura in a patient with liver
cirrhosis due to hepatitis C viral infection[J]. J Clin Exp
关系还需进一步验证，但新的风险信号的发现，可为临
Hematop，2013，53（2）：151-155.
床实践提供更多信息，也提示临床医务人员予以高度关
[12] MULLA C M，RASHIDI A，LEVITOV A B. Extensive ce‐
注，如发生相关ADE，应及时采取干预措施，从而保障患 rebral venous sinus thrombosis following a dose increase
者用药安全。 in eltrombopag in a patient with idiopathic thrombocytope‐
参考文献 nic purpura[J]. Platelets，2014，25（2）：144-146.
[ 1 ] PALANDRI F，ROSSI E，BARTOLETTI D，et al. Real- [13] ANDIC N，GUNDUZ E，AKAY O M，et al. Cardiac and
world use of thrombopoietin receptor agonists in older pa‐ pulmonary thrombosis during multidrug treatment in an
tients with primary immune thrombocytopenia[J]. Blood， idiopathic thrombocytopenic purpura patient[J]. Platelets，
2021，138（7）：571-583. 2014，25（1）：69-70.
[ 2 ] BIDIKA E，FAYYAZ H，SALIB M，et al. Romiplostim [14] OO Z，MANVAR K，WANG J C. Eltrombopag-induced
and eltrombopag in immune thrombocytopenia as a thrombocytosis and thrombosis in patients with antiphos‐
second-line treatment[J]. Cureus，2020，12（8）：e9920. pholipid syndrome and immune thrombocytopenic purpura
[ 3 ] MENG F Q，CHEN X Q，YU S J，et al. Safety and effi‐ [J]. J Investig Med High Impact Case Rep，2022，10：
cacy of eltrombopag and romiplostim in myelodysplastic 23247096211060581.
syndromes：a systematic review and meta-analysis[J]. [15] WU C，ZHOU X M，LIU X D. Eltrombopag-related renal
Front Oncol，2020，10：582686. vein thromboembolism in a patient with immune thrombo‐
[ 4 ] GHANIMA W，COOPER N，RODEGHIERO F，et al. cytopenia：a case report[J]. World J Clin Cases，2021，9
Thrombopoietin receptor agonists：ten years later[J]. Hae‐ （11）：2611-2618.
matologica，2019，104（6）：1112-1123. [16] GARABET L，GHANIMA W，HELLUM M，et al. In‐
[ 5 ] LOZANO M L，RODEGHIERO F. Thrombopoietin recep‐ creased microvesicle-associated thrombin generation in
tor agonist in chemotherapy-induced thrombocytopenia patients with immune thrombocytopenia after initiation of
[J]. Lancet Haematol，2022，9（3）：e168-e169. thrombopoietin receptor agonists[J]. Platelets，2020，31
[ 6 ] 李莉，杨卓，杨佳，等. 基于FAERS的阿达木单抗相关不 （3）：322-328.
良事件风险信号挖掘[J].中国药房，2022，33（16）：2006- [17] GHANIMA W，GEYER J T，LEE C S，et al. Bone marrow
2011. fibrosis in 66 patients with immune thrombocytopenia
LI L，YANG Z，YANG J，et al. Risk signal mining of ad‐ treated with thrombopoietin-receptor agonists：a single-
verse events related to adalimumab based on FAERS[J]. center，long-term follow-up[J]. Haematologica，2014，99
China Pharm，2022，33（16）：2006-2011. （5）：937-944.
[ 7 ] 曹珊珊，关月，张筱芳，等. 血小板生成素受体激动剂致 [18] QURESHI K，PATEL S，MEILLIER A. The use of throm‐
不良反应的文献分析[J]. 中国药物应用与监测，2022，19 bopoietin receptor agonists for correction of thrombocyto‐
（1）：34-38. penia prior to elective procedures in chronic liver di-
CAO S S，GUAN Y，ZHANG X F，et al. Literature analy‐ seases：review of current evidence[J]. Int J Hepatol，2016，
sis of adverse drug reaction induced by thrombopoietin 2016：1802932.
receptor agonists[J]. China Drug Appl Monit，2022，19 [19] GILREATH J，LO M，BUBALO J. Thrombopoietin recep‐
（1）：34-38. tor agonists （TPO-RAs）：drug class considerations for
[ 8 ] 侯明，胡豫. 成人原发免疫性血小板减少症诊断与治疗 pharmacists[J]. Drugs，2021，81（11）：1285-1305.
中国指南：2020 年版[J]. 中华血液学杂志，2020，41（8）： [20] VLACHODIMITROPOULOU E，CHEN Y L，GARBOWSKI
617-623. M，et al. Eltrombopag：a powerful chelator of cellular or
HOU M，HU Y. Chinese guidelines for the diagnosis and extracellular iron（Ⅲ） alone or combined with a second
treatment of primary immune thrombocytopenia in adults： chelator[J]. Blood，2017，130（17）：1923-1933.
2020 edition[J]. Chin J Hematol，2020，41（8）：617-623. [21] ZHAO Z，SUN Q，SOKOLL L J，et al. Eltrombopag mobi‐
[ 9 ] LOZANO M L，MINGOT-CASTELLANO M E，PERERA lizes iron in patients with aplastic anemia[J]. Blood，2018，
M M，et al. A decade of changes in management of im‐ 131（21）：2399-2402.
mune thrombocytopenia，with special focus on elderly pa‐ （收稿日期：2023-01-09 修回日期：2023-08-17）
tients[J]. Blood Cells Mol Dis，2021，86：102505. （编辑：胡晓霖）

中国药房 2023年第34卷第19期 China Pharmacy 2023 Vol. 34 No. 19 · 2395 ·